08/03/201621/10/2023 Helix BioPharma Corp. Reports on Advancement of Its L-DOS47 Phase I/II Study in Poland admin 0 Comments
03/03/201621/10/2023 Helix BioPharma Corp. Reports on Advancement of its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
29/01/201621/10/2023 Helix BioPharma Corp Announces Appointment of New Directors to the Board of Directors admin 0 Comments
21/01/201626/01/2024 Helix BioPharma Corp Initiates Enrollment In The Second Dosing Cohort Of U.S. Combination Treatment Study Of Its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
12/01/201626/01/2024 Helix BioPharma Corp Announces Appointment of Permanent New CEO and Changes at Board Level admin 0 Comments
06/01/201626/01/2024 Helix BioPharma Corp Signs License Agreement with Helix Polska to Develop Cancer Therapies in Poland admin 0 Comments